We are live on
!
Find out more
SWM
Stockman Wealth Management Portfolio holdings
AUM
$906M
1-Year Est. Return
22.23%
This Fund
S&P 500
This Quarter
Est. Return
+10.94%
1 Year Est. Return
+22.23%
3 Year Est. Return
+61.85%
5 Year Est. Return
+75.77%
10 Year Est. Return
+198.31%
AUM
$229M
AUM Growth
+$19.5M
(+9.3%)
Cap. Flow
-$1.5M
Cap. Flow
% of AUM
-0.66%
Top 10 Holdings %
Top 10 Hldgs %
27.02%
Holding
155
New
6
Increased
34
Reduced
59
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$5.67M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$3.64M |
| 3 |
Kraft Heinz
KHC
|
+$1.42M |
| 4 |
Phillips 66
PSX
|
+$781K |
| 5 |
AbbVie
ABBV
|
+$504K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Floating Rate Bond ETF
FLOT
|
+$5.76M |
| 2 |
AstraZeneca
AZN
|
+$3.89M |
| 3 |
Oracle
ORCL
|
+$1.54M |
| 4 |
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
|
+$1.04M |
| 5 |
Merck
MRK
|
+$962K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.81% |
| 2 | Technology | 13.43% |
| 3 | Energy | 11.39% |
| 4 | Financials | 10.56% |
| 5 | Consumer Staples | 7.76% |
Similar funds
HIGP
PSCM
PIP
EI
BDP
AOWM
OCA
AIC
Stockman Wealth Management's Q1 2019 Portfolio in Review
As of Q1 2019, Stockman Wealth Management held 155 positions worth $229M, up 9.3% from $209M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Stockman Wealth Management's Q1 2019 filing shows 6 new, 34 increased, 59 reduced and 6 closed positions. Its largest new stake was State Street SPDR Portfolio Short Term Corporate Bond ETF: 186,998 shares worth $5.71M. The largest sale was iShares Floating Rate Bond ETF, an estimated $5.76M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Technology and Energy.
- Stockman Wealth Management's largest Q1 2019 buy was State Street SPDR Portfolio Short Term Corporate Bond ETF: 186,998 shares worth $5.71M.
- Stockman Wealth Management added most to Bristol-Myers Squibb in Q1 2019, an estimated $3.64M increase.
- Stockman Wealth Management's biggest Q1 2019 reduction was AstraZeneca, cutting an estimated $3.89M.
- Stockman Wealth Management fully exited iShares Floating Rate Bond ETF in Q1 2019, selling an estimated $5.76M.
- Stockman Wealth Management's ten largest holdings make up 27% of its $229M portfolio in Q1 2019.
- Stockman Wealth Management opened 6 new positions and closed 6 in Q1 2019.
- Stockman Wealth Management's portfolio value rose 9.3% quarter-over-quarter to $229M.
Based on Stockman Wealth Management's 13F filing for Q1 2019, filed 7 May 2019.